Chat with us
Research Assistance
Online
  • Please enter your first name.

Japan Infectious Disease Molecular Diagnostics Market Size & Outlook

The infectious disease molecular diagnostics market in Japan is expected to reach a projected revenue of US$ 606.4 million by 2030. A compound annual growth rate of 7.1% is expected of Japan infectious disease molecular diagnostics market from 2025 to 2030.

  • Clinical Diagnostics
    • In Vitro Diagnostics
      • Infectious Disease Molecular Diagnostics Market Outlook
Revenue, 2024 (US$M)
$400.8
Forecast, 2030 (US$M)
$606.4
CAGR, 2025 - 2030
7.1%
Report Coverage
Japan

Japan Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)

Japan Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Global Market

Related Markets

Prism AI by Grand View ResearchFree to try

Ask a question about the infectious disease molecular diagnostics market

Every figure cited from GVR research

Japan infectious disease molecular diagnostics market highlights

  • The Japan infectious disease molecular diagnostics market generated a revenue of USD 400.8 million in 2024 and is expected to reach USD 606.4 million by 2030.
  • The Japan market is expected to grow at a CAGR of 7.1% from 2025 to 2030.
  • In terms of segment, reagents product was the largest revenue generating product in 2024.
  • Others Product is the most lucrative product segment registering the fastest growth during the forecast period.

Infectious disease molecular diagnostics market data book summary

Market revenue in 2024USD 400.8 million
Market revenue in 2030USD 606.4 million
Growth rate7.1% (CAGR from 2025 to 2030)
Largest segmentReagents product
Fastest growing segmentOthers Product
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments Product, Reagents Product, Others Product
Key market players worldwideAbbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp

Other key industry trends

  • In terms of revenue, Japan accounted for 2.5% of the global infectious disease molecular diagnostics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China infectious disease molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 899.7 million by 2030.

The infectious diseases molecular diagnostics market in Japan is estimated to exhibit a CAGR of 9.8% during the forecast period owing to presence of wellestablished public healthcare system and proactive government healthcare initiatives. 

These factors have made significant contribution to low mortality rate due to infectious diseases. Furthermore, high prevalence of target diseases, rise in awareness, and high geriatric population, which is susceptible to infectious diseases are other factors driving growth. 

Infectious diseases with highest mortality rate in Japan are influenza, infectious gastroenteritis, Tuberculosis (TB), and MRSA infections. Strategies being undertaken for geographic expansion in Asia Pacific by major U.S.-based players, to strengthen their position, are anticipated to drive the Japanese market. 

No credit card required*

Publish Date: Mar 04, 2025

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Infectious Disease Molecular Diagnostics Market Companies

NameProfile# EmployeesHQWebsite
Roche Holding AG ADRView profile 103,605Grenzacherstrasse 124, Basel, Switzerland, 4070www.roche.com
Abbott LaboratoriesView profile 114,000100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400www.abbottinvestor.com
Becton Dickinson & CoView profile 73,0001 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880www.bd.com
BioMerieux SAView profile 13,982Marcy l’Etoile, Lyon, France, 69280www.biomerieux.com
Siemens Healthineers AG ADRView profile 71,400Siemensstr. 3, Forchheim, BY, Germany, 91301www.siemens-healthineers.com
Danaher CorpView profile 63,0002200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701www.danaher.com
Illumina IncView profile 9,3005200 Illumina Way, San Diego, CA, United States, 92122www.illumina.com
Agilent Technologies IncView profile 17,7005301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051www.agilent.com
Bio-Rad Laboratories IncView profile 8,0301000 Alfred Nobel Drive, Hercules, CA, United States, 94547www.bio-rad.com
Qiagen NVView profile 5,900Hulsterweg 82, Venlo, LI, Netherlands, 5912 PLwww.qiagen.com

Japan Infectious Disease Molecular Diagnostics Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Infectious Disease Molecular Diagnostics Market Outlook will help companies and investors design strategic landscapes.


Reagents Product was the largest segment with a revenue share of 67.74% in 2024.

Horizon Databook has segmented the Japan infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.




The infectious diseases molecular diagnostics market in Japan is estimated to exhibit a CAGR of 9.8% during the forecast period owing to presence of wellestablished public healthcare system and proactive government healthcare initiatives. 

These factors have made significant contribution to low mortality rate due to infectious diseases. Furthermore, high prevalence of target diseases, rise in awareness, and high geriatric population, which is susceptible to infectious diseases are other factors driving growth. 

Infectious diseases with highest mortality rate in Japan are influenza, infectious gastroenteritis, Tuberculosis (TB), and MRSA infections. Strategies being undertaken for geographic expansion in Asia Pacific by major U.S.-based players, to strengthen their position, are anticipated to drive the Japanese market. 

  • Japan Infectious Disease Molecular Diagnostics Market Product Outlook (Revenue, USD Million , 2018-2030)
    • Instruments Product
    • Reagents Product
    • Services Product
  • Japan Infectious Disease Molecular Diagnostics Market Test location Outlook (Revenue, USD Million , 2018-2030)
    • Hospitals
    • Clinics
    • Diagnostics Laboratories
    • Research Institutes
  • Japan Infectious Disease Molecular Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
    • Polymerase Chain Reaction (PCR)
    • In Situ Hybridization
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and microarrays
    • Mass spectrometry
    • Transcription Mediated Amplification
    • Others
  • Japan Infectious Disease Molecular Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
    • Respiratory Diseases
    • Tuberculosis
    • Meningitis
    • Gastrointestinal Tract Infections
    • HPV
    • Sexually Transmitted Infection
    • Sepsis
    • Drug Resistance Disease
    • Others Application

Reasons to subscribe to Infectious Disease Molecular Diagnostics Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Infectious Disease Molecular Diagnostics Market Outlook databook

  • Our clientele includes a mix of Infectious Disease Molecular Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan Infectious Disease Molecular Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Infectious Disease Molecular Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Japan Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)

No Access Stack Chart

Japan infectious disease molecular diagnostics market statistics, by product, 2018-2030 (US$M)

No Access Pie Chart

Japan infectious disease molecular diagnostics market statistics, by product, 2018-2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more